Literature DB >> 8948319

Secondary hypertension: evaluation and treatment.

B E Akpunonu1, P J Mulrow, E A Hoffman.   

Abstract

Most patients with hypertension in the United States have essential (primary) hypertension (95%), the cause of which is unknown. The remaining 5% of adults with hypertension have the secondary form of hypertension, the cause and pathophysiologic process of which are known. Internists and other primary care physicians refer to this as treatable or curable hypertension, because the hypertension can be managed or even controlled with medications. Similarly, the condition is called surgical hypertension by surgeons in the belief that once the cause is determined and identified, surgical intervention will result in cure of hypertension. Secondary causes of hypertension include renal parenchymal disease, renovascular diseases, coarctation of the aorta, Cushing's syndrome, primary hyperaldosteronism, pheochromocytoma, hyperthyroidism, and hyperparathyroidism. Occasionally included in this category are alcohol- and oral contraceptive-induced hypertension and hypothyroidism, but these conditions are not discussed herein. The evaluation of secondary hypertension is of interest and can bring together different facets of anatomy, physiology, pharmacology, and radiology in the medical and surgical treatment of these disorders. Despite enthusiasm that can be generated in the evaluation of these conditions, evaluation can be expensive and should not be conducted for all patients with hypertension. Features that aid in the diagnosis of secondary hypertension include the following: 1. Onset of hypertension before the age of 20 or after the age of 50 years. The presence of hypertension at a young age may suggest coarctation of the aorta, fibromuscular dysplasia, or an endocrine disorder. Hypertension found for the first time after the age of 50 years may suggest the presence of renovascular hypertension caused by atherosclerosis. 2. Markedly elevated blood pressure or hypertension with severe end-organ damage, as in grade III or IV retinopathy. These findings suggest the presence of renovascular hypertension or pheochromocytoma. 3. Specific body habitus and ancillary physical findings. For example, truncal obesity and purple striae occur with hypercortisolism, and exophthalmos is associated with hyperthyroidism. 4. Resistant or refractory hypertension (poor response to medical therapy usually necessitating use of more than three antihypertensive medications from three different classes). 5. Specific biochemical test that suggest the existence of certain disorders, such as hypercalcemia in hyperparathyroidism, hyperglycemia in Cushing's syndrome and pheochromocytoma, and unprovoked hypokalemia with renin-producing tumors, primary hyperaldosteronism, or renin-mediated renovascular hypertension. 6. Other characteristics that may suggest secondary hypertension such as abdominal diastolic bruits (renovascular hypertension), decreased femoral pulses (coarctation of the aorta), or bitemporal hemianopias (Cushing's disease). A combination of a good history and physical examination, astute observation, and accurate interpretation of available data usually are helpful in the diagnosis of a specific causation.

Entities:  

Mesh:

Year:  1996        PMID: 8948319     DOI: 10.1016/s0011-5029(96)90019-x

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  9 in total

1.  [Secondary arterial hypertension in asymptomatic young man].

Authors:  P Ayuso Jiménez; C Fouz López; F Panadero Carlavilla; C Villa Poza
Journal:  Aten Primaria       Date:  2001-06-30       Impact factor: 1.137

Review 2.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

3.  Effects of tryptophan-containing peptides on angiotensin-converting enzyme activity and vessel tone ex vivo and in vivo.

Authors:  Sherif Khedr; Andreas Deussen; Irakli Kopaliani; Birgit Zatschler; Melanie Martin
Journal:  Eur J Nutr       Date:  2017-01-19       Impact factor: 5.614

4.  Plasma concentrations and ACE-inhibitory effects of tryptophan-containing peptides from whey protein hydrolysate in healthy volunteers.

Authors:  Melanie Martin; Diana Hagemann; Thinh Trung Nguyen; Lisa Schwarz; Sherif Khedr; Mats Leif Moskopp; Thomas Henle; Andreas Deussen
Journal:  Eur J Nutr       Date:  2019-05-03       Impact factor: 5.614

Review 5.  Echoes from Gaea, Poseidon, Hephaestus, and Prometheus: environmental risk factors for high blood pressure.

Authors:  Prateek Sharma; Robert D Brook
Journal:  J Hum Hypertens       Date:  2018-06-13       Impact factor: 3.012

Review 6.  Dental management in patients with hypertension: challenges and solutions.

Authors:  Janet H Southerland; Danielle G Gill; Pandu R Gangula; Leslie R Halpern; Cesar Y Cardona; Charles P Mouton
Journal:  Clin Cosmet Investig Dent       Date:  2016-10-17

7.  Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the Etiologies.

Authors:  Hyungwoo Ahn; Eun Ju Chun; Hak Jong Lee; Sung Il Hwang; Dong-Ju Choi; In-Ho Chae; Kyung Won Lee
Journal:  Korean J Radiol       Date:  2018-02-22       Impact factor: 3.500

8.  CaSR participates in the regulation of vascular tension in the mesentery of hypertensive rats via the PLC‑IP3/AC‑V/cAMP/RAS pathway.

Authors:  Wenwen Zhang; Ruixia Sun; Hua Zhong; Na Tang; Yongmin Liu; Yongli Zhao; Tian Zhang; Fang He
Journal:  Mol Med Rep       Date:  2019-08-27       Impact factor: 2.952

Review 9.  Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging.

Authors:  Duc Le; Lindsay Brown; Kundan Malik; Shin Murakami
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.